Press release
Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Leading Key Players are Boehringer Ingelheim GmbH (Germany) Elanco Animal Health Incorporated (US)
Companion Animal Pharmaceuticals Market
Browse in-depth TOC on "Companion Animal Pharmaceuticals Market"
143 – Tables
59 – Figures
238 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252218886&utm_source=openpr&utm_medium=paidpr
The growth in this market is majorly driven by the growth in companion animal ownership, rising prevalence of zoonotic diseases, rising demand for pet insurance with the growing animal health expenditure, and initiatives by various government agencies and animal associations. On the other hand, the limited number of new antibiotics, rising pet care costs, and rising cost of vaccine storage are expected to restrain the growth of this market during the forecast period.
By indication, the infectious diseases segment is expected to account for the largest share of the companion animal pharmaceuticals market
Based on indication, the global market is segmented into infectious diseases, dermatologic diseases, orthopedic diseases, pain, behavioral disorders, and other indications. The infectious diseases segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing prevalence of zoonotic diseases, growing rates of pet ownership, rising initiatives by government and animal health associations for controlling disease outbreaks, and easy accessibility of these drugs.
On the basis of animal type, dogs segment is expected to grow at highest CAGR in the market during the forecast period
Based on animal type, the companion animal pharmaceuticals market is segmented into dogs, cats, horses, and other companion animals. The dogs segment is projected to grow at the highest CAGR in the forecast period. This growth can be attributed to the increasing dog population and rising ownership rate, increasing prevalence of zoonotic diseases and other skin allergies in dogs, rising canine healthcare expenditure, and the increasing number of pet insurers across the globe.
On the basis of distribution channel, veterinary hospitals segment holds the largest market share in the companion animal pharmaceuticals market
Based on distribution channel, the market is segmented into veterinary hospitals, veterinary clinics, and retail pharmacies. The veterinary hospitals segment holds the largest share in the companion animal pharmaceuticals market due to the higher adoption of animal parasiticides and antibiotics in hospital settings, increasing incidence of infectious diseases, growing number of veterinary hospitals, growing ownership of companion animals, increasing veterinary expenditure, and growing awareness about animal health in developing countries.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=252218886&utm_source=openpr&utm_medium=paidpr
Asia Pacific is expected to register the highest CAGR in the market during the forecast period
The companion animal pharmaceuticals market in the APAC region is expected to register the highest CAGR during the forecast period. The rising pet ownership and increasing animal health expenditure, rising per capita income in these countries, increasing incidence of zoonotic diseases, increasing awareness on animal healthcare, growing number of veterinary hospitals and clinics, and the implementation of regulations to prevent the spread of animal diseases are the key factors driving market growth in this region.
Prominent players in the companion animal pharmaceuticals market include Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK), Chanelle Pharma (Ireland), Kyoritsu Seiyaku (Japan), Zydus Animal Health and Investments Limited (India), Tianjin Ringpu Bio-Technology Co., Ltd. (China), HIPRA (Spain), Norbrook Holdings Limited (UK), Inovet (Belgium), Endovac Animal Health (US), ECO Animal Health Group plc (UK), Indian Immunologicals Ltd. (India), ALS Pvt. Ltd. (India), and Lutim Pharma Pvt. Ltd. (India).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=252218886&utm_source=openpr&utm_medium=paidpr
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Leading Key Players are Boehringer Ingelheim GmbH (Germany) Elanco Animal Health Incorporated (US) here
News-ID: 2293176 • Views: …
More Releases from MarketsandMarkets™ INC.
Automotive V2X Market Size, Share, Industry Analysis by 2030
The global automotive V2X market is expected to grow from USD 0.5 billion in 2023 to USD 9.5 billion by 2030 at a CAGR of 51.9%. Government support toward C-V2X technology and improving road infrastructure is expected to support the automotive V2X market. Furthermore, the increasing adoption of V2X-equipped models such as Volkswagen ID 4, Volkswagen Golf, and Mercedes-Benz E-Class significantly impact the growth of the market. Moreover, Government regulations…
Automotive Software Market Size, Share, Trends & Forecast by 2030
The global automotive software market size was valued at USD 19.0 billion in 2023 and is expected to reach USD 32.3 billion by 2030, at a CAGR of 7.8%, during the forecast period 2023-2030. Rapid integration of ADAS features in vehicles, and increasing adoption of connected car services, paired with rising deployment of ECUs and domain controllers in vehicles are anticipated to increase the demand for automotive software all over…
Electric Vehicle Market Size, Share, Trends & Forecast by 2030
The global electric vehicle market size was valued at USD 388.1 billion in 2023 and is expected to reach USD 951.9 billion by 2030 at a CAGR of 13.7% during the forecast period 2023-2030. With advancements in technology, increasing environmental consciousness, and supportive government policies, EVs have gained significant traction as a viable and sustainable transportation option. As concerns over climate change and air pollution intensify, consumers and industries are…
Terminal Tractor Market Size, Share, & Trends by 2027
The terminal tractor market worldwide size was valued at USD 802 million in 2022 and is expected to reach USD 1,042 million by 2027, at a CAGR of 5.4% during the forecast period. A terminal tractor is a type of tractor intended to move semitrailers and containers in cargo yards, warehouse facilities, intermodal facilities, railway yards, airports, and other heavy industries. It has a short wheelbase with space to accommodate…
More Releases for Animal
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,…
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report…
Animal Hormones Market Brief Analysis By Top Key Players - Bayer Animal Health, …
MarketStudyReport.com adds a new 2018-2023 Global Animal Hormones Consumption Market Report focuses on the major drivers and restraints for the global key players providing analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Hormones Market by product type, application, key manufacturers and key regions. Over the next five years, Animal Hormones market will…
Global Animal Healthcare Market 2018 Key Players: Merck, Bayer Animal Health, Bo …
Animal Healthcare Market:
WiseGuyReports.com adds “Animal Healthcare Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” reports to its database.
Executive Summary
This report studies the global Animal Healthcare market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Animal Healthcare market by companies, region, type and end-use industry.
This report focuses on the global top players, covered
Merck
Bayer Animal Health
Boehringer Ingelheim Animal
Hipra
Phirbo Animal…
Companion Animal Healthcare Market 2023 Leading Players | Bayer Animal Health (G …
The Global Companion Animal Healthcare Market is expected to reach USD 20 billion by 2023 at a CAGR of 9.6% during forecast period 2017 to 2023.
Companion animals are pets which are kept for protection of a person, company, property or residence. These animals help to avoid theft and render safe environment. Dog and cats are the most popular pets. Companion animals play an important role in the lives of many,…
